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ABSTRACT: This study investigated serum lipid profile, liver function indices and electrolyte levels in diabetics and 
hepatitics in the University of Port Harcourt Teaching Hospital. 210 subjects comprising 70 subjects each for diabetics, 
hepatitics, and control matched for age and sex were sampled for the purpose of the study based upon specified criteria. 
45 each were males while 25 each were females. Mean alanine and aspartate aminotransferases (ALT and AST), alkaline 
phosphatase (ALP) and gamma glutamyltransferase (GGT) activities, respectively, were significantly elevated (p<0.05) in 
the diabetics (22 U/L, 30 U/L, 91 U/L, and 12 U/L respectively)  and hepatitics (86 U/L, 161 U/L, 113 U/L, and 50 U/L 
respectively); mean triglycerides (TG), total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) levels 
respectively, were significantly elevated (p<0.05) in the diabetics (1.8 mmol/L, 4.6 mmol/L, and 2.6 mmol/L 
respectively) and hepatitics (1.4 mmol/L, 3.6 mmol/L, and 1.8 mmol/L respectively) except the hepatitics mean LDL-C 
level, whereas mean high density lipoprotein-cholesterol (HDL-C) level was significantly reduced (p≥0.05) in the 
diabetics (1.2 mmol/L) and hepatitics (1.0 mmol/L). Mean sodium and potassium levels were significantly reduced 
(p≥0.05) in the diabetics (135 mmol/L and 3.5 mmol/L respectively). Mean sodium level was reduced in the hepatitics 
while mean potassium level was elevated in the hepatitics. Mean bicarbonate level was significantly elevated (p<0.05) in 
the diabetics (28 mmol/L) but slightly elevated in the hepatitics. Conclusively, differences in lipids, electrolyte levels and 
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Diabetes mellitus (DM) is associated with pervading 
alteration in lipid profile (Arora, 2010). Research has 
indicated that diabetics have a higher occurrence of 
liver and renal function dysfunction, besides 
production of free radicals due to glucose oxidation, 
non-enzymatic glycosylation of proteins and 
subsequent degeneration of glycated proteins 
produced by oxidation, proceeding to a reduction in 
antioxidant defence mechanisms activity and 
destruction of cellular organelles and enzymes, 
increased lipid peroxidation and insulin growth 
resistance (Arora, 2010). Hepatitis is arisen from 
noxious or contagious factors, of which 
hepatomegaly is a characteristic feature (Mathew et 
al., 2016). Various observational studies assessing 
the relationship between diabetes and hepatitis have 
been published (Negro and Alaei, 2009). The 
proposal that hepatitis C virus (HCV) may be 
associated with type 2 diabetes mellitus (T2DM) was 
first made by Allison in 1994. Nevertheless, 
researchers have provided inconclusive results, with a 
few researchers supporting the excess T2DM risk 
with HCV infection compared with non-HCV 
infected controls (Allison et al., 1994), and a few 
researchers indicated variations (Chehadeh et al., 
2009). Both diabetes and hepatitis are widespread, 
globally. The burden of HCV consistently increases 
due to hepatitis C-related disorders. From studies, 
33% of HCV subjects develop, minimally, an extra-
hepatic manifestation (Jacobson et al., 2010). A 
further similar previous study aimed at determining 
the links was conducted. It was based on an 
engrossing report (Marzouk et al., 2007). The authors 
sampled subjects and narrated the widespread of both 
diabetes and hepatitis. Previous studies suggested that 
HCV and diabetes result in elevated triglyceride (TG) 
level in humans with a higher elevation in diabetics 
(Perlemuter et al., 2002). It is directly related to the 
present study due to its connection by the study of 
TG in both as the determination of the state of the 
fatty liver is pertinent in the present. In this study, the 
serum lipid profile, liver function indices, and 
electrolyte levels of the diabetics and subjects with 
hepatic impairment (test groups) alongside the 
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control were investigated and compared. The 
research objectives were to ascertain the blood 
biochemical parameters levels in the diseases 
conditions under investigation for the management of 
these ailments, and to evaluate dyslipidaemia in 
sampled subjects. This study intends to make 
available some scientific information on lipid profile, 
liver and renal function statuses of diabetics and 
subjects with hepatic impairment. 
 
MATERIALS AND METHODS 
Study Area: The study was conducted in the 
Chemical Pathology Department of the University of 
Port Harcourt Teaching Hospital located in Choba, 
near Alakahia junction in Obio Akpor local 
government area (LGA), a LGA in Port Harcourt, the 
capital city of Rivers State, Nigeria. Rivers State was 
formed in 1967 by the Federal Government of 
Nigeria. Rivers State covers a land area of 21,850 sq. 
km. 
 
Equipment/Instruments: BSA 3000 Chemistry 
Analyzer (Model – 3000, Manufacturer – SFRI, 
France). 
UNISCOPE laboratory water bath (Model – Sm0147 
Water Bath Cabinet Model SM-8B, Manufacturer - 
Surgifriend Medicals, England). 
Universal 320 laboratory centrifuge (Model – Hettich 
Refrigerated Benchtop Centrifuge Model Universal 
320 R, Manufacturer - Hettich, Germany). 
Test-tubes, test- tube racks, pipette (5 ml, 10 ml), 
micropipette (0-100 µl, 100-1000 µl), micropipette 
tips, sample containers, plain bottles, syringes and 
needles, cotton wool, methylated spirit and 
tourniquette. 
 








Control Diabetic Hepatitic 
15-29 Venous blood 45 15 15 15 
30-44 Venous blood 45 15 15 15 
45-59 Venous blood 45 15 15 15 
60-74 Venous blood 45 15 15 15 
 







Control Diabetic Hepatitic 
15-29 Venous blood 25 9 8 8 
30-44 Venous blood 25 8 8 9 
45-59 Venous blood 25 8 9 8 
60-74 Venous blood 25 8 9 8 
 
Hepatitis and diabetes status were observed in 
patients seen in the University of Port Harcourt 
Teaching Hospital (UPTH) in 2017. Chart of 
diabetics and subjects with hepatic impairment was 
reviewed. 70 diabetic subjects (diabetics), 70 subjects 
with hepatic impairment, and 70 normal subjects 
(control), matched for age and sex were sampled for 
the purpose of the study based upon the following 
criteria: 
 
Inclusion criteria: All subjects aged between 15 to 74 
years attending the routine clinic at UPTH, and at the    
Medical Out-Patient (MOP) department that 
presented themselves. All subjects who agreed to 
participate in the research. 
 
Exclusion criteria: Subjects with co-infection with 
hepatitis delta (D) or other metabolic disorders. 
 
Ethical clearance: The proposal for the research was 
approved by the Research and Ethics Committee of 
both the University and UPTH before the research 
was commenced. Participating subjects/each 
participant provided consent on the available consent 
form. Subjects who suffered from diabetes or 
hepatitis were counselled appropriately. 
 
Experimental Subjects: A total of two hundred and 
ten (210) subjects were sampled for the purpose of 
the experiment. They consisted of seventy (70) 
subjects each for diabetics, hepatic impairment, and 
control matched for age and sex, and satisfying the 
eligibility criteria which was hepatitis and diabetes 
positivity in blood for a minimum of five months; 
exclusion of subjects with co-infection with hepatitis 
D; and inclusion of subjects between the ages of five 
(5) to eighty (80) who agreed to participate in the 
study after being given the informed consent form. 
 
Sample Collection and Preparation: Subjects were 
issued or given consent form to fill after listening to a 
detailed explanation from the researcher. 3-4 ml of 
blood samples were obtained by venipuncture using 5 
ml syringes and deposited into plain bottles. The 
samples were placed inside sample racks and 
incubated at 25oC for a minimum of 30 minutes. The 
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serum samples were centrifuged for 5 minutes to 
obtain a completely clear sample. 
 
Lipid Profile Assays: Determination of serum 
triglyceride (TG) level was done using the Agappe 
test kits for triglycerides. Normal range of TG in 
serum is ≤2.3mmol/l (Thefeld et al., 1994). 
Concerning total cholesterol (TC) determination, 
blood cholesterol level was determined using the 
serum and Agappe test kits for cholesterol. Reference 
range of TC level in serum is ≤5.2mmol/l (Thefeld et 
al., 1994). Determination of high density lipoprotein-
cholesterol (HDL-C) level was done using the serum 
and Agappe test kits for HDL-C. Normal range of 
HDL-C in serum is 0.9 -1.6mmol/l (Thefeld et al., 
1994). The serum low density lipoprotein-cholesterol 
(LDL-C) was calculated by Friedewald equation. 
Normal range of LDL-C in serum is 1.3 -2.6mmol/l 
(Thefeld et al., 1994). 
 
Enzyme Assays: Determination of the serum aspartate 
aminotransferase (AST) activity was done at 37oC 
using the Agappe test kits by measuring the amount 
of oxaloacetate formed in the presence of L-aspartate 
and alpha-ketoglutarate as reported by Thefeld et al., 
(1994). Normal range of AST in serum is 1-46U/l 
(Thefeld et al., 1994). For alanine aminotransferase 
(ALT), L-alanine replaced L-aspartate whereas 
pyruvate replaced oxaloacetate. Determination of the 
serum ALT activity was done using Agappe test kits 
(Thefeld et al., 1994). Normal range of ALT present 
in serum is 1-49U/l (Thefeld et al., 1994). Normal 
range of gamma glutamyltransferase (GGT) in serum 
is 5-32U/l in female, and 7-45U/l in male (Thefeld et 
al., 1994). Determination of the serum GGT activity 
was done using Agappe test kits whereas the serum 
alkaline phosphatase (ALP) activity was determined 
using the Agappe test kits and monitored the amount 
of inorganic phosphate released from p-nitrophenyl 
phosphate following the procedure of Thefeld et al., 
(1994). Normal range of ALP in serum is 64-306U/l 
for women, and 80-306U/l for men (Thefeld et al., 
1994).  
 
Electrolyte Assays: The determination of sodium ion 
(Na+) in the serum samples was performed at 25oC by 
colorimetric method. Sodium and proteins are 
precipitated together by magnesium uranyl acetate as 
uranyl magnesium sodium acetate salt. Excess of 
uranyl salt reacts with potassium ferrocyanide to 
produce a brownish colour. The intensity of the 
colour is inversely proportional to the sodium 
concentration in the specimen and is measured 
photometrically at 530 nm. Normal range of Na+ in 
serum is 135-145 mmol/l (Thefeld et al., 1994). The 
determination of potassium ion (K+) in the serum 
samples was performed at 25oC by turbidometric 
method based on the principle of reacting sodium-
tetraphenylborate with K+ to yield potassium-
tetraphenylborate and Na+ (Engelbrecht and McCoy, 
2002). The extent of turbidity is proportional to the 
potassium concentration and is measured 
photometrically at 578 nm (Engelbrecht and McCoy, 
2002). Normal range of K+ in serum is 3.5-5.5 
mmol/l (Thefeld et al., 1994). The determination of 
bicarbonate ion (HCO3-) in the serum samples was 
also performed at 25oC using the back titration 
method which involves a simple reaction between 
acid and base. The bicarbonate reagent utilizes the 
enzymatic method (Tietz, 1990). In this procedure, 
bicarbonate (HCO3-) and phosphoenolpyruvate (PEP) 
are converted to oxaloacetate and phosphate in the 
reaction catalyzed by phosphoenolpyruvate 
carboxylase (PEPC). Malate dehydrogenase (MDH) 
catalyzes the reduction of oxaloacetate to malate with 
the concomitant oxidation of reduced nicotinamide 
adenine dinucleotide (NADH). This oxidation of 
NADH results in a reduction in absorbance of the 
reaction mixture measured bichromatically at 
380/410nm proportional to the bicarbonate content of 
the sample. Normal range of HCO3- in serum is 24-30 
mmol/l (Thefeld et al., 1994). 
 
Statistical Analysis: All data were subjected to 
statistical analysis. Statistical analysis was performed 
using SPSS version 20.0 (IBM, U.S.A). The data 
were analyzed using one-way analysis of variance 
(ANOVA) and significant differences were 
determined using post Hoc Duncan multiple 
comparison test (p<0.05). The results were 
considered significant at 95% confidence level. The 
values are represented as mean ± standard deviation 
(SD). 
 
RESULTS AND DISCUSSION 
The results obtained for the serum lipid profile, liver 
function indices, and electrolyte levels of the various 
parameters determined are presented in Figures 1-10. 
The reduction of HDL-C level in subjects with 
hepatic impairment in this research was compatible 
with previous researchers (Cicognani et al., 1997).  
 
Due to the fact that much of the measured HDL-C 
was synthesized in the liver, major damages to 
hepatocytes, such as those caused by alcohol 
consumption or chronic viral hepatitis may generate 
anomalous liver function and moderate reduction in 
HDL-C and TC levels (Cicognani et al., 1997). 
Lipids have been observed to play a significant role 
in immune host response to infections (Grunfeld and 
Feingold, 1992). 
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For diabetics, low HDL-C level was equivalent to 
high TC level. Diabetic patients had elevated liver 
marker enzymes values that were within the normal 
range. Diabetes does not indicate liver damage but 
can elevate the possibility of chronic liver disease 
independent of viral hepatitis, as the prevalence of 
elevated liver marker enzymes in diabetic patients 
was considerably higher than expected (Kim et al., 
2004). Electrolytes such as sodium and potassium 
assist in the maintenance of the body electrolyte and 
water balance (Nguyen and Kurtz, 2004). 
 
 
Fig 1: Descriptive report on the age groups of the diabetic subjects 
(diabetics) and hepatitic subjects (subjects with hepatic 
impairment). This figure shows the number of subjects in the 
various age groups listed above. The number of subjects in age 
group 45-59 is a direct opposite of that in age group 15-29 while 
the number of subjects in age group 60-74 is a direct opposite of 
that in age group 30-44. 
 
Elevated ALT value was noted in 42.7% of the 
diabetics and in 58.6% of the hepatitic subjects. ALT 
performs the catalysis of the reversible 
transamination between L-alanine and α-
ketoglutarate to yield pyruvate and L-glutamate as 
such possessing a relevant function in amino acid 
metabolism and gluconeogenesis. The reaction 
remains reversible, but the ALT reaction equilibrium 
favours L-alanine formation. ALT activity is found 
primarily in the liver (Mathur et al., 2016). Further 
elucidation may be up-regulation of ALT activity. 
Among the amino acids, the utmost effective 
precursor for gluconeogenesis is alanine. 
Gluconeogenesis is elevated in T2DM subjects due to 
increased substrate delivery (e.g., alanine) and an 
increased conversion of alanine to glucose. ALT may 
thus be up-regulated as a remediable response to the 
diminished effect of hepatic insulin signalling or, in 
an alternative way, might leak more comfortably 
away from the hepatocytes due to fatty infiltration 
and subsequent destruction (Schindhelm et al., 2006). 
 
Fig 2: Serum lipid profile in the diabetics and hepatitics (subjects 
with hepatic impairment). Values are mean ± standard deviation 
(SD). Values with the same superscript (a) are significantly 
different (p<0.05) compared with the control.  
 
 
Fig 3: Serum lipid profile in the male diabetics and hepatitics 
(subjects with hepatic impairment). Values are mean ± standard 
deviation (SD). Values with the same superscript (a) are 
significantly different (p<0.05) compared with the control.  
 
Elevated AST value was noted in 50.4% of the 
diabetics and in 68.6% of the hepatitic subjects 
(Mathur et al., 2016). The activity of AST, an 
aminotransferase, is frequently measured; this 
enzyme role is customarily to transfer the amino 
group from an amino acid, aspartate in the case of 
AST, to a keto acid, yielding oxaloacetate and 
pyruvate, respectively. It is seen in hepatocyte 
cytoplasm; an alternative type of AST is also seen in 
hepatocyte mitochondria. Notwithstanding that both 
aminotransferases; AST, and ALT, are generally 
circulated in further body tissues, AST activities 
outside the liver are reduced and, thus, considered to 
be more specific for hepatocellular destruction (Boon 
et al., 2006). 
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Fig 4: Serum lipid profile in the female diabetics and hepatitics 
(subjects with hepatic impairment). Values are mean ± standard 
deviation (SD). Values with the same superscript (a) are 
significantly different (p<0.05) compared with the control.  
 
 
Fig 5: Serum liver marker enzymes activity (liver function index) 
in the diabetics and hepatitics (subjects with hepatic impairment). 
Values are mean ± standard deviation (SD). Values with the same 
superscript (a) are significantly different (p<0.05) compared with 
the control. 
 
Elevated ALP value was noted in 41.1% of the 
diabetics and in 49.4% of the hepatitic subjects. 
T2DM exists as a metabolic syndrome in which fat 
metabolism is dysregulated and there is consequent 
increase of FFA resulting in subsequent fatty liver. 
ALP is seen to be associated with cell membrane 
which connects the bile canaliculus, and so highly 
elevated serum concentration of the liver isoenzyme 
signifies cholestasis preferably to barely destruction 
to the hepatocytes (Mathur et al., 2016). According to 
a study by Southampton University hospitals, 60 
diabetics stabilized on oral hypoglycaemic agents or 
insulin, and routine tests, specifically saw their ALP 
level rise anomalously although barely to more than 
twice the normal upper limit. It may be concluded 
that this notable liver function disease is rare among 
stabilized diabetics (Foster et al., 2013). 
 
 
Fig 6: Serum liver marker enzymes activity (liver function index) 
in the male diabetics and hepatitics (subjects with hepatic 
impairment). Values are mean ± standard deviation (SD). Values 
with the same superscript (a) are significantly different (p<0.05) 
compared with the control. 
 
 
Fig 7: Serum liver marker enzymes activity (liver function index) 
in the female diabetics and hepatitics (subjects with hepatic 
impairment). Values are mean ± standard deviation (SD). Values 
with the same superscript (a) are significantly different (p<0.05) 
compared with the control. 
 
Elevated GGT value was noted in 48.9% of the 
diabetics and in 59.2% of the hepatitic subjects 
(Mathur et al., 2016). Elevated TG value was noted 
in 75.6% of the diabetics and in 58.3% of the 
hepatitic subjects (Tietz, 1990). Elevated TC value 
was noted in 82.7% of the diabetics and in 60.5% of 
the hepatitic subjects (Third Report of the NCEP, 
2001). Reduced HDL-C value was noted in 4.3% of 
the diabetics and in 30.7% of the hepatitic subjects 
(Third Report of the NCEP, 2001). Elevated LDL-C 
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value was noted in 93.8% of the diabetics and in 
4.9% of the hepatitic subjects (Third Report of the 
NCEP, 2001). Reduced Na+ value was noted in 
71.8% of the diabetics and in 73.4% of the hepatitic 
subjects (Tietz, 1990). Reduced K+ value was noted 
in 78.6% of the diabetics and in 82.2% of the 
hepatitic subjects (Tietz, 1990). Elevated bicarbonate 
value was noted in 53.5% of the diabetics and in 
4.7% of the hepatitic subjects (Tietz, 1990). 
 
 
Fig 8: Serum electrolyte levels in the diabetics and hepatitics 
(subjects with hepatic impairment). Values are mean ± standard 
deviation (SD). Values with the same superscript (a) are 
significantly different (p<0.05) compared with the control. 
 
 
Fig 9: Serum electrolyte levels in the male diabetics and hepatitics 
(subjects with hepatic impairment). Values are mean ± standard 
deviation (SD). Values with the same superscript (a) are 
significantly different (p<0.05) compared with the control.  
 
Type 2 diabetic subjects were shown to be associated 
with large occurrence of anomalous tests compared 
with non-diabetic subjects, with elevated ALT values 
being the most usual anomaly. A cross sectional 
study from Iran demonstrated ALT and AST 
elevation which was 10.4% and 3.3% respectively in 
type 2 diabetics (Meybodi et al., 2008). Based on a 
research conducted in Sudan, where 50 diabetic 
subjects and 30 normal control subjects were tested 
for liver function, ALT, AST, and GGT mean values 
were shown to be significantly elevated among 
diabetic subjects compared with the control. 
However, the values were within the normal range 
(Idris et al., 2011). Based on Vozarova et al., the 
liver marker enzymes; ALT, AST and ALP were 
estimated to be significantly elevated in diabetics in 
comparison to the control (Vozarova et al., 2002). 
 
 
Fig 10: Serum electrolyte levels in the female diabetics and 
hepatitics (subjects with hepatic impairment). Values are mean ± 
standard deviation (SD). Values with the same superscript (a) are 
significantly different (p<0.05) compared with the control.  
 
Electrolyte balances derangement may occur in DM, 
arising from hyperglycaemia, hyperketonaemia, and 
insulin deficiency. The present study showed a 
majorly significant reduction in Na+ and K+ serum 
values in DM. This result was consistent with those 
reported in previous studies. Below physiologic 
conditions, most of Na+ is reabsorbed in the kidneys’ 
proximal tubule (Guyton and Hall, 2006). The 
relative insulin deficiency present in DM decreases 
lipoprotein lipase action effect and leads to reduced 
HDL-C levels and elevated TG levels, which may be 
improved with enhanced glycemic control (Brunzell 
and Chait, 1997). 
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Conclusion: An elevation in mean serum potassium 
in hepatitics was observed due to damage by the 
hepatitis virus which could lead to glomerular 
filtration pattern change since potassium is much 
involved in the glomerular basement membrane and 
reabsorbed in the tubules. Hepatitis appeared to 
produce a more dysfunctional state to subjects 
compared with diabetes despite the complications 
associated with diabetes. Differences in lipids, 
electrolyte levels and liver function indices found in 
diabetics and hepatitics have a great potential as a 
diagnostic means in clinical practice. 
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